Hearing aid industry association responds to FDA's proposed OTC regulation

The Hearing Industries Association (HIA) has provided the US Food and Drug Administration with a list of recommendations to ensure users of new over-the-counter hearing aids aren't harmed, once the prescriptionless sales channel opens sometime this year.

More precise measures must be included in the rules for the upcoming over-the-counter (OTC) sales of hearing aids in the US, ensuring that new devices are safe for users who choose to circumvent the hitherto required appointment with an audiologist.

This is the response from the Hearing Industries Association (HIA), which falls shortly before the deadline set by the US Food and Drug Administration (FDA) for industry feedback. The FDA proposed the new rules for the OTC sales channel in fall last year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs